Quest Diagnostics (DGX) Short term Debt (2009 - 2026)

Quest Diagnostics has disclosed Short term Debt across 18 years of filings, most recently posting $503.0 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $503.0 million, up 50200.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $503.0 million (up 50200.0% YoY), and the FY2025 annual result was $504.0 million, down 16.28% from the prior year.
• Short term Debt came in at $503.0 million for Q1 2026 at Quest Diagnostics, roughly flat from $504.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $906.0 million in Q1 2024 to a low of $1.0 million in Q1 2025.
• The 5-year median for Short term Debt is $503.0 million (2026), against an average of $345.2 million.
• Across the five-year window, Short term Debt slumped 99.89% in 2025 and jumped 50200.0% in 2026, its largest moves.
• Quest Diagnostics' Short term Debt stood at $2.0 million in 2022, then soared by 15050.0% to $303.0 million in 2023, then surged by 98.68% to $602.0 million in 2024, then declined by 16.28% to $504.0 million in 2025, then fell by 0.2% to $503.0 million in 2026.
• The last three Short term Debt figures came in at $503.0 million (Q1 2026), $504.0 million (Q4 2025), and $504.0 million (Q3 2025), per Business Quant data.